Dr. Richard Helmers
I've won the following awards
Outstanding Clinician Award, American Thoracic Society
Outstanding Clinician Award, Arizona Thoracic Society
Outstanding Faculty Presenter, Mayo School of Continuous Professional Development
Excellence in Teaching Recognition, Mayo Clinic College of Medicine
Excellence in Teaching, Mayo Clinic College of Medicine
Presidential Commendation, American Thoracic Society
Scanlon Symposium Memorial Lecturer, Society of Thoracic Radiology
Who's Who in American Thoracic Society, American Thoracic Society
House Staff Teacher of the Year, St. Luke's Hospital (Milwaukee, WI)
Senior Class Resident of the Year, University of Iowa College of Medicine
The expanding role(s) of eosinophils in health and disease.
Blood., Nov;120(19):3882-90 (2012)
Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red".
J. Allergy Clin. Immunol., Sep;130(3):572-84 (2012)
A sensitive high throughput ELISA for human eosinophil peroxidase: a specific assay to quantify eosinophil degranulation from patient-derived sources.
J. Immunol. Methods., Oct;384(1-2):10-20 (2012)
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a systematic overview.
Am. J. Respir. Crit. Care Med., Jul;184(1):8-16 (2011)
Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus.
Mayo Clin. Proc., Dec;80(12):1558-67 (2005)
Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast.
JAMA., Feb;279(6):455-7 (1998)
Determinants of survival in idiopathic pulmonary fibrosis.
Am. J. Respir. Crit. Care Med., Feb;149(2 Pt 1):450-4 (1994)
Determinants of progression in idiopathic pulmonary fibrosis.
Am. J. Respir. Crit. Care Med., Feb;149(2 Pt 1):444-9 (1994)
Outcome of subjects with idiopathic pulmonary fibrosis who fail corticosteroid therapy. Implications for further studies.
Chest., Jan;103(1):69-73 (1993)
Bronchoalveolar lavage cellularity. The distribution in normal volunteers.
Am. Rev. Respir. Dis., Aug;146(2):448-53 (1992)
Determinants of bronchoalveolar lavage cellularity in idiopathic pulmonary fibrosis.
J. Appl. Physiol., Nov;71(5):1688-93 (1991)
The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis.
Am. Rev. Respir. Dis., Sep;144(3 Pt 1):504-6 (1991)
Sarcoidosis and giant splenomegaly.
Sarcoidosis., Sep;7(2):119-22 (1990)
Bronchoalveolar lavage in the nonimmunocompromised patient.
Chest., Nov;96(5):1184-90 (1989)
Bronchoalveolar lavage in interstitial lung disease: effect of volume of fluid infused.
J. Appl. Physiol., Oct;67(4):1443-6 (1989)
Serial exercise testing in pulmonary embolism.
Chest., Sep;94(3):517-20 (1988)
Bronchoalveolar lavage and opportunistic pulmonary infections.
Mayo Clin. Proc., Jul;62(7):630-1 (1987)